EP3334432
CERDULATINIB FOR TREATING MYELOMA
:
EP einkaleyfi: Þýðing ekki lögð inn:
12.8.2016:
23.2.2022:
16835995.8
:
11.8.2036
:
CERDULATINIB FOR TREATING MYELOMA
12.8.2016
23.2.2022
:
Portola Pharmaceuticals, Inc.:
270 East Grand Avenue Suite 22, South San Francisco, California 94080, US
:
COFFEY, Gregory:
South San Francisco, California 94080, US
:
FENG, Jiajia:
South San Francisco, California 94080, US
:
201562204400 P:
12.8.2015:
US
:
201662342711 P:
27.5.2016:
US
:
US2016046862:
12.8.2016
:
A61K 31/506, A61K 31/551, C07D 279/12, A61K 45/06, A61P 35/02